acheteur Représailles de la part de jnj medical devices division Collier un million Crasseux
Bayer Executive Joins Johnson & Johnson as CIO - WSJ
Johnson and Johnson Medical Devices Companies | HT Medical Devices
J&J division buys medical device maker
Johnson & Johnson MedTech France | LinkedIn
Medical Device Sales Overview Guide: Johnson & Johnson
J&J, HP team up for 3-D printing of personalized healthcare products | Fierce Biotech
J&J to restructure orthopedic business after medical device sales miss | Reuters
J&J to buy cardiovascular technology Abiomed in USD 16.6B deal
Johnson & Johnson Will Break Itself Up Into Two Companies - The New York Times
J&J upbeat on 2023 as devices rebound post-COVID, shares jump | Reuters
Orthotaxy acquisition boosts Johnson & Johnson medical device division
Le sous-traitant Jabil reprend 14 sites de Johnson & Johnson - VIPress.net
Johnson & Johnson se tourne vers Wall Street pour valoriser sa division santé grand public
J&J splits off consumer health division | BioWorld
Johnson Johnson Medical Products Company In Markham Ontario Stock Photo - Download Image Now - iStock
A Closer Look at Johnson & Johnson's Medical Devices Business | The Motley Fool
J&J is latest big pharma, device company to call it splits with consumer health - MedCity News
J&J Beats Profit Estimates on Pharmaceutical, Medtech Sales as COVID-19 Shot Revenue Slows
Name change for Johnson & Johnson division as they embrace MedTech — Connect Macquarie Park Innovation District
J&J's pipeline includes 30 'major' medical devices and a surgical robot - MassDevice
Johnson & Johnson Medical Devices Companies fait l'acquisition d'Orthotaxy afin de développer la nouvelle génération de plateforme de chirurgie robotique assistée pour l'orthopédie.
J&J to spin off consumer products and focus on pharmaceuticals | Reuters
J&J Makes a $16.6 Billion Bet on Heart Pumps to Lift Medical-Device Sales - WSJ
J&J says it will split into two companies in 2022
Résultats : J&J se redresse avant une année charnière
Johnson & Johnson: Dividend Stock Analysis (NYSE:JNJ) | Seeking Alpha